Semaglutide

PCOS doesn’t go away. It’s a lifelong condition that changes its expression as you age, but the underlying metabolic vulnerability persists.

GLP-1 receptor agonists like semaglutide and tirzepatide are changing the treatment picture for polycystic ovary syndrome.

Introduction Exercise improves insulin sensitivity, lowers androgen levels, reduces inflammation, and helps with the depression and anxiety that are disproportionately common in PCOS. But…

There’s no single “PCOS diet,” but there are dietary patterns with real clinical evidence behind them.

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting roughly 1 in 10 worldwide.

Introduction The evidence base for PCOS treatment has grown substantially over the past two decades, though it still lags behind other common conditions in…

The hardest question in CKD care isn’t which drug to use; it’s when to start.

Here’s the uncomfortable truth: by the time most people feel something wrong with their kidneys, they’ve already lost half their function.

The treatment landscape for chronic kidney disease has changed more in the last five years than in the previous twenty.